Neuroprotective and disease-modifying effects of the ketogenic diet
The ketogenic diet has been in clinical use for over 80 years, primarily for the symptomatic treatment of epilepsy. A recent clinical study has raised the possibility that exposure to the ketogenic di
http://www.pubmedcentral.nih.gov/articlerender.fcg...
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
Abstract Background Alzheimer's disease (AD) is characterized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivat
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's diseas...